1 year return (CAGR)
233.50%
Taysha Gene Therapies Inc Exchange (NASDAQ, USD)
TSHA
4.79
-0.31 (-4.44%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
109.07%
5 year return (CAGR)
-23.71%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.92B
Price/Sales
196.11
Ent value
1.69B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 6.95 |
| Daily high | 7.03 |
| Daily low | 6.46 |
| Daily Volume | 2.55M |
| All-time high | 31.75 |
| 1y analyst estimate | 13.33 |
| Beta | 1.19 |
| EPS (TTM) | -0.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TSHA | S&P500 | |
| Current price drop from All-time high | -84.91% | -1.38% |
| Highest price drop | -98.14% | -56.47% |
| Date of highest drop | 28 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -76.75% | -10.68% |
| Avg time to new high | 202 days | 12 days |
| Max time to new high | 1331 days | 1805 days |
News
